UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Journal of hepatology, 2019-09, Vol.71 (3), p.543-552

2019

Volltextzugriff (PDF)

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

The Lancet (British edition), 2017-06, Vol.389 (10088), p.2492-2502

2017

Volltextzugriff (PDF)

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.154-159

2018

Volltextzugriff (PDF)

Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life

Value in health, 2016-09, Vol.19 (6), p.788-794

2016

Volltextzugriff (PDF)

Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients

Indian journal of psychological medicine, 2017-05, Vol.39 (3), p.342-346

2017

Volltextzugriff (PDF)

Povidone-iodine for the management of oral mucositis during cancer therapy

Oncology Reviews, 2017-09, Vol.11 (2), p.341-341

2017

Volltextzugriff (PDF)

Outcome of advanced lung cancer with central airway obstruction versus without central airway obstruction

ERJ open research, 2018-04, Vol.4 (2), p.173

2018

Volltextzugriff (PDF)

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Current drug discovery technologies, 2016-06, Vol.13 (2), p.68-76

2016

Volltextzugriff (PDF)

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Journal of clinical oncology, 2018-05, Vol.36 (14), p.1412-1418

2018

Volltextzugriff (PDF)

SPECIFIC LEARNING DISORDER IN CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER

Journal of evidence based medicine and healthcare, 2018-10, Vol.5 (44), p.3114-3118

2018

Volltextzugriff (PDF)

Effectiveness of EGFR-tyrosine kinase inhibitors (TKI) versus EGFR-TKIs plus talc pleurodesis in preventing recurrence of malignant pleural effusion (MPE) in advanced lung adenocarcinoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21684-e21684

2016

Volltextzugriff (PDF)

Abiraterone or Enzalutamide in Advanced Castration‐Resistant Prostate Cancer: An Indirect Comparison

The Prostate, 2017-05, Vol.77 (6), p.639-646

2017

Volltextzugriff (PDF)

Comparative effective analysis between enzalutamide and abiraterone in the treatment of metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.217-217

2013

Volltextzugriff (PDF)

Subglottic Extramedullary Plasmacytoma With Light Chain Multiple Myeloma Masquerading as Adult-Onset Asthma

Journal of voice, 2014-05, Vol.28 (3), p.394.e1-394.e4

2014

Volltextzugriff (PDF)

Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison: Abiraterone or Enzalutamide in Advanced Prostate Cancer

The Prostate, 2017-05, Vol.77 (6), p.639-646

2017

Volltextzugriff (PDF)

RF3-A Impact of Treatment Subsidies and Cash Pay-Outs on Treatment Choices at the End of Life

Journal of pain and symptom management, 2016-12, Vol.52 (6), p.e47-e47

2016

Volltextzugriff (PDF)

Corrigendum to “Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis” [J Hepatol 71 (2019) 543–552]

Journal of hepatology, 2019-12, Vol.71 (6), p.1278-1278

2019

Volltextzugriff (PDF)

Significance of coexistent granulomatous inflammation and lung cancer

Journal of clinical pathology, 2017-04, Vol.70 (4), p.337-341

2017

Volltextzugriff (PDF)

Tu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1234-S-1234

2018

Volltextzugriff (PDF)

Impact of antitumor activity on survival outcomes, and nonconventional benefit, with nivolumab (NIVO) in patients with advanced hepatocellular carcinoma (aHCC): Subanalyses of CheckMate-040

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.475-475

2018

Volltextzugriff (PDF)

Comparative effectiveness of front-line agents in the treatment of metastatic clear cell renal cell carcinoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15045-e15045

2012

Volltextzugriff (PDF)

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

BMC cancer, 2014-08, Vol.14 (1), p.592, Article 592

2014

Volltextzugriff (PDF)

Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time

Medicine (Baltimore), 2015-07, Vol.94 (29), p.e1216-e1216

2015

Volltextzugriff (PDF)

Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study

Annals of oncology, 2017-10, Vol.28 Suppl 9, p.ix87

2017

Volltextzugriff (PDF)

Phase I/II safety and antitumor activity of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (HCC): Interim analysis of the CheckMate-040 dose escalation study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4012-4012

2016

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(20)
Humans
(13)
Male
(12)
Technology
(12)
Middle Aged
(8)
Engineering
(7)
Female
(7)
Aged
(6)
Oncology
(6)
Adult
(5)
Aged, 80 And Over
(5)
Computer Science
(5)
Engineering, Electrical & Electronic
(5)
Optimization
(5)
Patients
(5)
Physical Sciences
(5)
Respiratory System
(5)
Signal To Noise Ratio
(5)
Wireless Communications
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA

Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life

Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients

Povidone-iodine for the management of oral mucositis during cancer therapy

Outcome of advanced lung cancer with central airway obstruction versus without central airway obstruction

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

SPECIFIC LEARNING DISORDER IN CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER

Effectiveness of EGFR-tyrosine kinase inhibitors (TKI) versus EGFR-TKIs plus talc pleurodesis in preventing recurrence of malignant pleural effusion (MPE) in advanced lung adenocarcinoma

Abiraterone or Enzalutamide in Advanced Castration‐Resistant Prostate Cancer: An Indirect Comparison

Comparative effective analysis between enzalutamide and abiraterone in the treatment of metastatic castration-resistant prostate cancer

Subglottic Extramedullary Plasmacytoma With Light Chain Multiple Myeloma Masquerading as Adult-Onset Asthma

Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison: Abiraterone or Enzalutamide in Advanced Prostate Cancer

RF3-A Impact of Treatment Subsidies and Cash Pay-Outs on Treatment Choices at the End of Life

Corrigendum to “Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis” [J Hepatol 71 (2019) 543–552]

Significance of coexistent granulomatous inflammation and lung cancer

Tu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study

Impact of antitumor activity on survival outcomes, and nonconventional benefit, with nivolumab (NIVO) in patients with advanced hepatocellular carcinoma (aHCC): Subanalyses of CheckMate-040

Comparative effectiveness of front-line agents in the treatment of metastatic clear cell renal cell carcinoma

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time

Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study

Phase I/II safety and antitumor activity of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (HCC): Interim analysis of the CheckMate-040 dose escalation study

Suchergebnisse filtern